Alnylam Pharmaceuticals I... (ALNY)
NASDAQ: ALNY
· Real-Time Price · USD
456.35
-4.64 (-1.01%)
At close: Oct 03, 2025, 3:59 PM
455.47
-0.19%
After-hours: Oct 03, 2025, 07:00 PM EDT
-1.01% (1D)
| Bid | 448 |
| Market Cap | 59.82B |
| Revenue (ttm) | 2.46B |
| Net Income (ttm) | -319.09M |
| EPS (ttm) | -2.49 |
| PE Ratio (ttm) | -183.27 |
| Forward PE | 75.45 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 471.4 |
| Volume | 931,815 |
| Avg. Volume (20D) | 1,154,287 |
| Open | 465.00 |
| Previous Close | 460.99 |
| Day's Range | 448.47 - 465.00 |
| 52-Week Range | 205.87 - 484.21 |
| Beta | 0.35 |
| Ex-Dividend Date | n/a |
About ALNY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALNY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALNY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAlnylam Pharmaceuticals Inc. is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-2.66%
Alnylam Pharmaceuticals shares are trading lower a...
Unlock content with
Pro Subscription
3 weeks ago
+0.67%
Alnylam shares are trading lower after the company announced a proposed $500 million offering of convertible senior notes due 2028.
